Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Stage at Diagnosis and Comorbidity Influence Breast Cancer Survival in First Nations Women in Ontario, Canada

Amanda J. Sheppard, Anna M. Chiarelli, Loraine D. Marrett, E. Diane Nishri and Maureen E. Trudeau
Amanda J. Sheppard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna M. Chiarelli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loraine D. Marrett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Diane Nishri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maureen E. Trudeau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-11-0459 Published October 2011
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Indigenous populations in Canada and abroad have poorer survival after a breast cancer diagnosis compared with their geographic counterparts; however, the influence of many demographic, personal, tumor, and treatment factors has not been examined to describe this disparity according to stage at diagnosis.

Methods: A case–case design was employed to compare First Nations (FN) women (n = 287) to a frequency-matched random sample of non-FN women (n = 671) diagnosed with breast cancer within the Ontario Cancer Registry. Women were matched on period of diagnosis (1995–1999 and 2000–2004), age at diagnosis (<50 vs. ≥50), and Regional Cancer Centre (RCC). Stage and other factors were collected from medical charts at the RCCs. Survival was compared using an adjusted Cox proportional hazards model and stratified by stage at diagnosis (I, II, and III–IV). Determinants of survival in FN women stratified by stage at diagnosis were also modeled.

Results: Survival was more than three times poorer for FN women diagnosed at stage I than for non-FN women (HR = 3.10, 95% CI = 1.39–6.88). The risk of death after a stage I breast cancer diagnosis was about five times higher among FN women with a comorbidity other than diabetes (HR = 4.65, 95% CI = 1.39–15.53) and was more than five times greater for women with diabetes (HR = 5.49, 95% CI = 1.69–17.90) than for those without a comorbidity.

Conclusions: Having a preexisting comorbidity was the most important factor in explaining the observed survival disparity among FN women.

Impact: Improving the general health status of FN women could increase their survival after an early-stage breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev; 20(10); 2160–7. ©2011 AACR.

This article is featured in Highlights of This Issue, p. 1991

  • Received May 20, 2011.
  • Revision received July 13, 2011.
  • Accepted July 25, 2011.
  • ©2011 American Association for Cancer Research.
View Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 20 (10)
October 2011
Volume 20, Issue 10
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Stage at Diagnosis and Comorbidity Influence Breast Cancer Survival in First Nations Women in Ontario, Canada
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Stage at Diagnosis and Comorbidity Influence Breast Cancer Survival in First Nations Women in Ontario, Canada
Amanda J. Sheppard, Anna M. Chiarelli, Loraine D. Marrett, E. Diane Nishri and Maureen E. Trudeau
Cancer Epidemiol Biomarkers Prev October 1 2011 (20) (10) 2160-2167; DOI: 10.1158/1055-9965.EPI-11-0459

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Stage at Diagnosis and Comorbidity Influence Breast Cancer Survival in First Nations Women in Ontario, Canada
Amanda J. Sheppard, Anna M. Chiarelli, Loraine D. Marrett, E. Diane Nishri and Maureen E. Trudeau
Cancer Epidemiol Biomarkers Prev October 1 2011 (20) (10) 2160-2167; DOI: 10.1158/1055-9965.EPI-11-0459
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Grant Support
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Urinary Melatonin in Relation to Breast Cancer Risk
  • Endometrial Cancer and Ovarian Cancer Cross-Cancer GWAS
  • Risk Factors of Subsequent CNS Tumor after Pediatric Cancer
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement